Literature DB >> 15830481

5-fluorocytosine and amphotericin B in bronchial secretions.

J E Pennington, E R Block, H Y Reynolds.   

Abstract

The penetration into and clearance from bronchial secretions of 5-fluorocytosine and amphotericin B were studied in a dog model. After a single intravenous dose of 35 mg/kg, 5-fluorocytosine intrabronchial concentrations were greater than the minimal inhibitory concentration for 80 to 90% of Candida species. These inhibitory concentrations persisted up to 3 h. In contrast, amphotericin B in intravenous doses of 0.6 and 1.2 mg/kg penetrated the blood-bronchus barrier poorly.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15830481      PMCID: PMC444645          DOI: 10.1128/AAC.6.3.324

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  AMPICILLIN IN THE THERAPY OF CHRONIC BRONCHITIS.

Authors:  J R MAY
Journal:  Postgrad Med J       Date:  1964-12       Impact factor: 2.401

2.  TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN: SOME PHARMACOLOGICAL OBSERVATION.

Authors:  J R MAY; D M DELVES
Journal:  Lancet       Date:  1965-05-01       Impact factor: 79.321

3.  OCULAR PENETRATION OF AMPHOTERICIN B: A REPORT OF LABORATORY STUDIES AND A CASE REPORT OF POSTSURGICAL CEPHALOSPORIUM ENDOPHTHALMITIS.

Authors:  W R GREEN; J E BENNETT; R D GOOS
Journal:  Arch Ophthalmol       Date:  1965-06

4.  Some aspects of the absorption, distribution, and excretion of amphotericin B in man.

Authors:  D B LOURIA
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1958-05

Review 5.  Chemotherapy of systemic mycoses (second of two parts).

Authors:  J E Bennett
Journal:  N Engl J Med       Date:  1974-02-07       Impact factor: 91.245

6.  Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man.

Authors:  E R Block; J E Bennett; L G Livoti; W J Klein; R R MacGregor; L Henderson
Journal:  Ann Intern Med       Date:  1974-05       Impact factor: 25.391

Review 7.  The role of antibiotics in the pathogenesis of Candidainfections.

Authors:  M S Seelig
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

8.  Concentrations of gentamicin and carbenicillin in bronchial secretions.

Authors:  J E Pennington; H Y Reynolds
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

9.  Pharmacological studies with 5-fluorocytosine.

Authors:  E R Block; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

10.  Oropharyngeal cultures of patients in protected environment units: evaluation of semiquantitative technique during antibiotic prophylaxis.

Authors:  D A Johnston; G P Bodey
Journal:  Appl Microbiol       Date:  1972-05
View more
  6 in total

1.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Drug treatment of pneumonia in the hospital. What are the choices?

Authors:  M Aoun; J Klastersky
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 3.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

Review 4.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

5.  Removal of endobronchial mucormycosis lesion through a rigid bronchoscope.

Authors:  S al-Majed; F al-Kassimi; M Ashour; M O Mekki; S Sadiq
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139

Review 6.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.